Kanazawa K, Soma T
Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1058-61.
Over the past 20 years the survival rate for advanced stomach cancer among Japanese remains the same. In order to increase the survival rate, 17 years ago we initiated a type of preoperative irradiation therapy as an adjunct to surgery. We have tried to develop an adequate plan for indication of preoperative irradiation. The results obtained were as follows. 1. In this study we used a computer simulated method which aided in determining a suitable plan for adjunct irradiation therapy. 2. The adequate total dosage ranged 3,000 +/- 1,000 rads, with a 2 weeks waiting period between irradiation treatment and surgery, especially for advanced gastric cancer invading to ss and up to 6 cm in diameter. 3. Histopathological findings from resected specimen, using pH 4.1 TBM staining method, indicated decrease in the depth of the carcinoma and extent and size of the tumor as well as degeneration and/or disappearance of the cancer cells due to the preoperative therapy. 4. We identified the decrease of metastatic rates of the regional lymphnodes in the irradiation group. 5. Clinical results indicated an improved resectability rate of 6.1% and an approximate 12.1% increase in the 5 years survival rate.
在过去20年里,日本晚期胃癌的生存率一直保持不变。为了提高生存率,17年前我们开始采用一种术前放射治疗作为手术的辅助手段。我们试图制定一个合适的术前放射治疗适应症方案。得到的结果如下。1. 在本研究中,我们使用了计算机模拟方法,这有助于确定辅助放射治疗的合适方案。2. 合适的总剂量范围为3000 +/- 1000拉德,在放射治疗和手术之间有2周的等待期,特别是对于侵犯至ss且直径达6厘米的晚期胃癌。3. 使用pH 4.1 TBM染色法对切除标本进行组织病理学检查,结果表明术前治疗使癌的深度、肿瘤的范围和大小减小,以及癌细胞变性和/或消失。4. 我们发现放射治疗组区域淋巴结转移率降低。5. 临床结果显示可切除率提高了6.1%,5年生存率大约提高了12.1%。